Tell how much it costs to develop drugs at your company at the Life Sci VC site. Bruce Booth, a partner at Atlas Venture, established the form to provide information in response to the Slate article highlighting results from Light and Warburton study that estimated median drug development costs at $43 M vs. PhRMA cost estimate of $1.32 B, or Tufts inflation adjusted $1.2 B estimate. What is the real cost? Maybe we can get a thrid consensus figure from an informed developer population. That is the hope.
I picked this up on Derek Lowe's In the Pipeline site, along with Derek's congratulations to the folks at HGS for getting Benlysta approved. Derek could not help but note that Benlysta took a wee bit long to make it to the approval column at FDA - having started in 2000 and very likely costing a wee bit more than $43 M to get to market.
By the way, even in approval, HGS has promised to run some additional trials with African-American populations which presumably are free and not part of developing a drug.
Posted by Bruce Lehr March 10th 2011.
Comments